3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Not yet recruiting
2
Completed
2
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
2
Anemia, Refractory, with Excess of Blasts
1
Interventions
Specimen Handling
76
Cisplatin
64
Drug Therapy
63
Carboplatin
63
Bevacizumab
63
Magnetic Resonance Spectroscopy
59
Radiotherapy
57
Gemcitabine
54
Cyclophosphamide
54
pembrolizumab
52
Oxaliplatin
49
Capecitabine
49
toripalimab
44
Paclitaxel
40
tislelizumab
39
Standard of Care
39
fludarabine
36
Injections
34
Fluorouracil
34
Biopsy
34
venetoclax
33
Blood Specimen Collection
31
Immune Checkpoint Inhibitors
30
anlotinib
28
Nivolumab
28
Surgical Procedures, Operative
27
Irinotecan
27
Docetaxel
27
Leucovorin
26
Dexamethasone
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
treosulfan
×
1 year
×
Clear all
NCT07598110
2026-05-20
FT-RIC-HAPLO
Institut Paoli-Calmettes
Phase 2
Not yet recruiting
77 enrolled
NCT07025824
2025-09-03
RELEVANT
Technische Universität Dresden
Phase 2
Not yet recruiting
220 enrolled